Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2023-01-30 00:00:00 ET · period of report 2023-01-27 · accession 0001209191-23-005484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-30 | 2023-01-27 | GMED | Lemaitre Dan | Dir | M - OptEx | $12.59 | +5,250 | 5,250 | New | +$66.1K |
| D | 2023-01-30 | 2023-01-27 | GMED | Lemaitre Dan | Dir | M - OptEx | $0.00 | -5,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-27 | M | A | 5,250 | $12.59 | 5,250 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2023-01-27 | M | D | 5,250 | $0.00 | 0 | D | $12.59 · — to 2023-01-30 | 5,250 Class A Common Stock | (F1) These options were granted on January 30, 2013 and are fully vested. |